VLX Ventures creates and invests in early-stage startups led by exceptional entrepreneurs. It's sweet spots are data driven, biotechnology and computational biology companies. VLX makes follow-on investments.VLX highly versatile and experienced team provides entrepreneurs with extensive mentoring and networking support. Its experience and know-how, combined with our financial backing, give early-stage startups the tools they need to grow and thrive.VLX’s major shareholder, CBG (UK), has invested >$600m in Israel in several leading funds and companies.

Omnix Medical is bringing the next generation of highly effective antibiotics - to win the war against drug-resistant bacteria

Immunyx Pharma is a nanotechnology drug development company focused on modulating neutrophil function to treat disease.Using this platform technology to specifically manipulate neutrophils using a targeted nanoparticle, Immunyx will bring new therapies to several diseases where neutrophil treatment could advance a cure (Colitis, COPD, Cancer, Arthritis etc.)

Protica Bio is combining cutting-edge proteomics with articifical inteligence to discover novel drug targets and immunotherpy response markers to significantly improve cancer treatment

Harnessing novel molecular insights & deep computational biology for unprecedented decision-support in fertility care (IVF)

Sakura Bio is developing revolutionary, off-the-shelf, allogeneic T-Cell therapy against aggresive tumors

Disrupting the ophthalmology eyedrops market by commercializing a nano-tech -based slow-release plug to deliver drugs

Pyxis develops a diagnostics platform for predicting immunotherapy drug response, and for the discovery of new drug and combinations, by mapping the tumor-immune communication network and developing unique computational tools.

Xenia Venture Capital is an investment company publicly traded in the Tel-Aviv Stock Exchange that operated a tech incubator, and is engaged in the initiation and build-up of high-technology start up companies in Israel, in the fields of Information Technology and Life Science.

SAManage was acquired by Solarwinds for $350M

Joined SanDisk as part of the company’s $1.6 Bn acquisition of m-systems (NSDQ: FLSH) in 2006.Generated partnerships with global Tier-1 players in the Mobile industry (mainly chipset & handset vendors) and managed the tech and marketing aspects of the activity. Successfully drove these eco-system players to adapt their products to enable SanDisk to offer its products to the cellular market. e.g.: Qualcomm, Texas Instruments, Motorola, HTC, LGE, Broadcom

M-Systems was a global leader and innovator of Flash memory storage products. Developed and patented the first flash drive and the first USB flash drive. Revenues exceeded $1Bn. M-systems was acquired by San-Disk for $1.6Bn.

Led a team that successfully launched the first 3G handsets in Israel (Orange). A member in Hutchison's global Handset Group which defined the group’s handsets' strategy and roadmap. Took active part in launch of the first 3G handsets worldwide, together with Nokia & LGE.

Partner Future Comm. was the corporate fund of Hutchison, focused on investments in start up companies developing innovative technologies and services for the Tlecom market.